Terpenes in Mushrooms: Natural Products with Diverse Therapeutic Activities

Year 2026, Volume: 46 Issue: 1, 61 - 71, 01.03.2026

Eda Avcı , Ayşe Kuruüzüm-uz , Didem Şöhretoğlu

https://doi.org/10.52794/hujpharm.1790368

https://izlik.org/JA83LW68FL

Abstract

This study provides a comprehensive review of the terpenes found in mushrooms and their potential therapeutic applications. Mushrooms are rich sources of various terpenes, including monoterpenes, sesquiterpenes, diterpenes, and triterpenes, which possess antibacterial, antiviral, antifungal, antiparasitic, antioxidant, anti-inflammatory, antidiabetic, and cytotoxic activities. Notable examples include pleuromutilin, a precursor of the antibiotic retapamulin; ganoderic acids from Ganoderma lucidum with anti-HIV effects; sesquiterpenes from Albatrellus dispansus that are effective against phytopathogenic fungi; and lanostane triterpenes from G. lucidum and G. leucocontextum with neuroprotective effects. The present findings highlight the therapeutic potential of mushroom terpenes. However, the authors underscore the necessity for further in vitro studies to elucidate the mechanisms of action, along with in vivo studies, toxicity investigations, and clinical trials.

Keywords

Bioactive compounds , Mushrooms , Natural products , Terpenes , Therapeutic applications

Ethical Statement

not applicable

Supporting Institution

not applicable

Project Number

not applicable

Thanks

not applicable

References

• 1. Muszyńska B, Grzywacz-Kisielewska A, Kała K, Gdula-Argasińska J. Anti-inflammatory properties of edible mushrooms: A review. Food Chem. 2018;243:373-381. https://doi.org/10.1016/j.foodchem.2017.09.149
• 2. Dasgupta A, Acharya K. Mushrooms: an emerging resource for therapeutic terpenoids. 3 Biotech. 2019;9(10):369. https://doi.org/10.1007/s13205-019-1906-2
• 3. Alves MJ, Ferreira ICFR, Dias J, Teixeira V, Martins A, Pintado M. A review on antifungal activity of mushroom (Basidiomycetes) extracts and isolated compounds. Curr. Top. Med. Chem. 2013;13(21):2648-2659. https://doi.org/10.2174/15680266113136660191
• 4. Duru ME, Tel Çayan G. Biologically active terpenoids from mushroom origin: A review. Nat. Prod. 2015;9:456-483. https://acgpubs.org/doc/2018080722372458-RNP-1412-266.pdf
• 5. Chen HP, Liu JK. Secondary metabolites from higher fungi. Prog. chem. org. nat. prod. 2017;106:1-201. https://doi.org/10.1007/978-3-319-59542-9_1
• 6. El Enshasy HA, Hatti-Kaul R. Mushroom immunomodulators: unique molecules with unlimited applications. Trends Biotechnol. 2013;31(12):668-677. https://doi.org/10.1016/j.tibtech.2013.09
• 7. El-Maradny YA, El-Fakharany EM, Abu-Serie MM, Hashish MH, Selim HS. Lectins purified from medicinal and edible mushrooms: Insights into their antiviral activity against pathogenic viruses. Int. J. Biol. Macromol. 2021;179:239-258. https://doi.org/10.1016/j.ijbiomac.2021.03.015
• 8. Assemie A, Abaya G. The effect of edible mushroom on health and their biochemistry. Int. J. Microbiol. 2022;(1):8744788. https://doi.org/10.1155/2022/8744788
• 9. Cör D, Knez Ž, Knez Hrnčič M. Antitumour, antimicrobial, antioxidant and antiacetylcholinesterase effect of Ganoderma lucidum terpenoids and polysaccharides: A review. Molecules. 2018;23(3):649. https://doi.org/10.3390/molecules23030649
• 10. Fendoğlu B, Kuruüzüm-Uz A, Şöhretoğlu D. Mantarlardan elde edilen alkaloitler. Mantar Dergisi. 2018;9(2):117-125. https://doi.org/10.30708/mantar.415589
• 11. Venturella G, Ferraro V, Cirlincione F, Gargano ML. Medicinal mushrooms: Bioactive compounds, use, and clinical trials. Int. J. Mol. Sci. 2021;22(2):634. https://doi.org/10.3390/ijms22020634
• 12. Güngör E, Altop A, Erener G. Mantarların (Basidiomycota) kanatlı hayvanlarda performans, ürün kalitesi, antioksidan aktivite, bağırsak mikrobiyotası ve bağışıklık üzerine etkileri. Poultry studies. 2017;14(2):18-29. https://dergipark.org.tr/tr/download/article-file/420037
• 13. Öztürk A, Çopur ÖU. Mantar Bileşenlerinin Teröpatik Etkileri. Bahçe. 2009;38(1):19-24. https://dergipark.org.tr/tr/download/article-file/39679
• 14. González-Hernández RA, Valdez-Cruz NA, Macías-Rubalcava ML, Trujillo-Roldán, MA. Overview of fungal terpene synthases and their regulation. World J. Microbiol. Biotechnol. 2023;39(7):194. https://doi.org/10.1007/s11274-023-03635-y
• 15. Zjawiony JK. Biologically active compounds from Aphyllophorales (polypore) fungi. J. Nat. Prod. 2004;67(2):300-310. https://doi.org/10.1021/np030372w
• 16. Aramabašić Jovanović J, Mihailović M, Uskoković A, Grdović N, Dinić S, Vidaković M. The effects of major mushroom bioactive compounds on mechanisms that control blood glucose level. J. Fungi. 2021;7(1):58. https://doi.org/10.3390/jof7010058
• 17. Yaoita Y, Kikuchi M, Machida K. Terpenoids and sterols from some Japanese mushrooms. Nat. Prod. Commun. 2014;9(3):419-426. http://dx.doi.org/10.1177/1934578X1400900332
• 18. Zhao S, Gao Q, Rong C, Wang S, Zhao Z, Liu Y, et al. Immunomodulatory effects of edible and medicinal mushrooms and their bioactive immunoregulatory products. J. Fungi. 2020;6(4):269. https://doi.org/10.3390/jof6040269
• 19. Liu D-Z. A review of ergostane and cucurbitane triterpenoids of mushroom origin. Nat. Prod. Res, 2014;28(14):1099-1105. https://doi.org/10.1080/14786419.2014.900767
• 20. Soares A, de Sá-Nakanishi A, Bracht A, da Costa S, Koehnlein E, de Souzam C, et al. Hepatoprotective effects of mushrooms. Molecules. 2013;18(7):7609-7630. https://doi.org/10.3390/molecules18077609
• 21. Teplyakova TV, Kosogova TA. Antiviral effect of Agaricomycetes mushrooms (Review). Int. J. Med. Mushrooms. 2016;18(5):375-386. https://doi.org/10.1615/intjmedmushrooms.v18.i5.10
• 22. Gressler M, Löhr NA, Schäfer T, Lawrinowitz S, Seibold PS, Hoffmeister D. Mind the mushroom: natural product biosynthetic genes and enzymes of Basidiomycota. Nat. Prod. Rep. 2021;38(4):702-722. https://doi.org/10.1039/D0NP00077A
• 23. Quin MB, Flynn CM, Schmidt-Dannert C. Traversing the fungal terpenome. Nat. Prod. Rep. 2014;31(10):1449-1473. https://doi.org/10.1039/C4NP00075G
• 24. Pennerman KK, Yin G, Bennett JW. Health effects of small volatile compounds from East Asian medicinal mushrooms. Mycobiology. 2015;43(1):9-13. https://doi.org/10.5941/MYCO.2015.43.1.9
• 25. Fogarasi M, Socaci SA, Dulf FV, Diaconeasa ZM, Fărcas AC, Tofană M, et al. Bioactive compounds and volatile profiles of five transylvanian wild edible mushrooms. Molecules, 2018;23(12). https://doi.org/10.3390/molecules23123272
• 26. Taşkın H, Çelik ZD, Bozok F, Cabaroğlu T, Büyükalaca S. First report on volatile composition of Tricholoma anatolicum in comparison with Tricholoma caligatum. Rec. Nat. Prod. 2019;13(6):446-455. https://doi.org/10.25135/rnp.122.18.12.1095
• 27. Wang S, Bao L, Zhao F, Wang Q, Li S, Ren J, et al. Isolation, identification, and bioactivity of monoterpenoids and sesquiterpenoids from the mycelia of edible mushroom pleurotus cornucopiae. J. Agric. Food Chem. 2013;61(21):5122-5129. https://doi.org/10.1021/jf401612t
• 28. Abraham WR. Bioactive sesquiterpenes produced by fungi: are they useful for humans as well? Curr. Med. Chem. 2001;8:583-606. https://doi.org/10.2174/0929867013373147
• 29. Wang S, Chen R, Yuan L, Zhang C, Liang D, Qiao J. Molecular and functional analyses of characterized sesquiterpene synthases in mushroom-forming fungi. J. Fungi. 2023;9(10). https://doi.org/10.3390/jof9101017
• 30. Lin H, Ji-Kai L. The first humulene type sesquiterpene from Lactarius hirtipes. Z. Naturforsch C. J. Biosci. 2002;57:571-574. https://doi.org/10.1515/znc-2002-7-803
• 31. Zhou J, Feng T, Ye R. Differentiation of eight commercial mushrooms by electronic nose and gas chromatography-mass spectrometry. J. Sens. 2015;1:474013. https://doi.org/10.1155/2015/374013
• 32. Li N, Li H, Liu Z, Feng G, Shi C, Wu Y. Unveiling the therapeutic potentials of mushroom bioactive compounds in alzheimer’s disease. Foods. 2023;12(15):2972. https://doi.org/10.3390/foods12152972
• 33. Tang H-Y, Yin X, Zhang C-C, Jia Q, Gao J.M. Structure diversity, synthesis, and biological activity of cyathane diterpenoids in higher fungi. Curr. Med. Chem. 2015;22(19):2375-2391. https://doi.org/10.2174/0929867322666150521091333
• 34. Yadav SK, Ir R, Jeewon R, Doble M, Hyde KD, Kaliappan I, et al. A mechanistic review on medicinal mushrooms-derived bioactive compounds: Potential mycotherapy candidates for alleviating neurological disorders. Planta Med. 2020;86(16):1161-1175. https://doi.org/10.1055/a-1177-4834
• 35. Clericuzio M, Mellerio GG, Finzi PV, Vidari G. Secondary metabolites isolated from Tricholoma species (Basidiomycota, Tricholomatacee): a review. Nat. Prod. Commun. 2018;13(9):1213-1224. http://dx.doi.org/10.1177/1934578X1801300926
• 36. Feng T, He J, Ai HL, Huang R, Li ZH, Liu JK. Three new triterpenoids from European mushroom Tricholoma terreum. Nat. Prod. Bioprospect. 2015;5(4):205-208. https://doi.org/10.1007/s13659-015-0071-5
• 37. Mothana RAA, Jansen R, Jülich WD, Lindequist U. Ganomycins A and B, new antimicrobial farnesyl hydroquinones from the basidiomycete Ganoderma pfeifferi. J. Nat. Prod. 2000;63(3):416-418. https://doi.org/10.1021/np990381y
• 38. Ameri A, Vaidya JG, Deokule SS. İn vitro evaluation of anti-staphylococcal activity of Ganoderma lucidum, Ganoderma praelongum and Ganoderma resinaceum from Pune, India. Afr. J. Microbiol. Res. 2019;13(1):1-9. https://doi.org/10.5897/AJMR11.070
• 39. Wisetsai A, Lekphrom R, Bua-Art S, Suebrasri T, Boonlue S, Tontapha S, et al. Scalarane sesterterpenoids with antibacterial and anti-proliferative activities from the mushroom Neonothopanus nambi. Molecules. 2021;26(24):7667. https://doi.org/10.3390/molecules26247667
• 40. Liu YP, Dai Q, Wang WX, He J, Li ZH, Feng T, et al. Psathyrins: Antibacterial diterpenoids from Psathyrella candolleana. J. Nat. Prod. 2020;83(5):1725-1729. https://doi.org/10.1021/acs.jnatprod.0c00269
• 41. Wu H, Yang HX, Li ZH, Feng T, Liu JK. Psathyrellins A-E, antibacterial guanacastane diterpenoids from mushroom Psathyrella candolleana. Nat. Prod. Bioprospect. 2021;11(4):447-452. https://doi.org/10.1007/s13659-021-00316-x
• 42. Ma JX, Cai CS, Liu JJ, Gao S, Zhao GZ, He XW. İn vitro antibacterial and antitumor activity of total triterpenoids from a medicinal mushroom Sanghuangporus sanghuang (Agaricomycetes) in liquid fermentation culture. Int. J. Med. Mushrooms. 2021;23(7):27-39. https://doi.org/10.1615/IntJMedMushrooms.2021038916
• 43. El-Mekkawy S, Meselhy MR, Nakamura N, Tezuka Y, Hattori M, Kakiuchi N, et al. Anti-HIV-1 and anti-HIV-1-protease substances from Ganoderma lucidum. Phytochemistry. 1998;49(6):1651-1657. https://doi.org/10.1016/s0031-9422(98)00254-4
• 44. Mothana RAA, Ali NAA, Jansen R, Wegner U, Mentel R, Lindequist U, et al. Antiviral lanostanoid triterpenes from the fungus Ganoderma pfeifferi. Fitoterapia. 2003;74:177-180. https://doi.org/10.1016/s0367-326x(02)00305-2
• 45. Niedermeyer THJ, Lindequist U, Mentel R, Gördes D, Schmidt E, Thurow K, et al. Antiviral terpenoid constituents of Ganoderma pfeifferi. J. Nat. Prod. 2005;68(12):1728-1731. https://doi.org/10.1021/np0501886
• 46. Sato N, Zhang Q, Ma C-M, Hattori M. Anti-human immunodeficiency virus-1 protease activity of new lanostane-type triterpenoids from Ganoderma sinense. Chem. Pharm. Bull. 2009;57(10):1076-1080. https://doi.org/10.1248/cpb.57.1076
• 47. Wang Y, Bao L, Yang X, Li L, Li S, Gao H, et al. Bioactive sesquiterpenoids from the solid culture of the edible mushroom Flammulina velutipes growing on cooked rice. Food Chem. 2012;132(3):1346-1353. https://doi.org/10.1016/j.foodchem.2011.11.117
• 48. Luo D-Q, Wang F, Bian X-Y, Liu J-K. Rufuslactone, a new antifungal sesquiterpene from the fruiting bodies of the Basidiomycete Lactarius rufus. J. Antibiot. 2005;58(7):456-459. https://doi.org/10.1038/ja.2005.60
• 49. Quack W, Anke T, Oberwinkler F, Giannetti BM, Stegich W. Antibiotics from Basidiomycetes. V. Merulidial, a new antibiotic from the Basidiomycete Merulius tremellosus Fr. J. Antibiot. 1978;31(8):737-741. https://doi.org/10.7164/antibiotics.31.737
• 50. Schüffler A, Wollinsky B, Anke T, Liermann JC, Opatz, T. Isolactarane and sterpurane sesquiterpenoids from the basidiomycete Phlebia uda. J. Nat. Prod. 2012;75(7):1405-1408. https://doi.org/10.1021/np3000552
• 51. Ma K, Ren J, Han J, Bao L, Li L, Yao Y, et al. Ganoboninketals A-C, antiplasmodial 3,4-seco-27-norlanostane triterpenes from Ganoderma boninense Pat. J. Nat. Prod. 2014;77(8):1847-1852. https://doi.org/10.1021/np5002863
• 52. Adams M, Christen M, Plitzko I, Zimmermann S, Brun R, Kaiser M, et al. Antiplasmodial lanostanes from the Ganoderma lucidum mushroom. J. Nat. Prod. 2010;73(5):897-900. https://doi.org/10.1021/np100031c
• 53. Mallick S, Dey S, Mandal S, Dutta A, Mukherjee D, Biswas G, et al. A novel triterpene from Astraeus hygrometricus induces reactive oxygen species leading to death in Leishmania donovani. Future Microbiol. 2015;10(5):763-789. https://doi.org/10.2217/fmb.14.149
• 54. Souza-Fagundes EM, Cota BB, Rosa LH, Romanha AJ, Corrêa-Oliveira R, Rosa CA, et al. İn vitro activity of hypnophilin from Lentinus strigosus: A potential prototype for chagas disease and leishmaniasis chemotherapy. Braz. J. Med. Biol. Res. 2010;43(11):1054-1061. https://doi.org/10.1590/S0100-879X2010007500108
• 55. Shen C-C, Wang Y-H, Chang T-T, Lin L-C, Don M-J, Hou Y-C, et al. Anti-inflammatory ergostanes from the Basidiomata of Antrodia salmonea. Planta Med. 2007;73(11):1208-1213. https://doi.org/10.1055/s-2007-981591
• 56. Smina TP, De S, Devasagayam TPA, Adhikari S, Janardhanan KK. Ganoderma lucidum total triterpenes prevent radiation-induced DNA damage and apoptosis in splenic lymphocytes in vitro. Mutat. Res. - Genet. Toxicol. Environ. Mutagen. 2011;726(2):188-194. https://doi.org/10.1016/j.mrgentox.2011.09.005
• 57. Zhu M, Chang Q, Wong LK, Chong FS, Li RC. Triterpene antioxidants from Ganoderma lucidum. Phytother. Res. 1999;13:529-531. https://doi.org/10.1002/(sici)1099-1573(199909)13:6%3C529::aid-ptr481%3E3.0.co;2-x
• 58. Alzand KI, Ünal S, Mostafa Boufaris MS. Lanostane-type triterpenes and abietane-type diterpene from the sclerotia of chaga medicinal mushroom, Inonotus obliquus (Agaricomycetes), and their biological activities. Int. J. Med. Mushrooms. 2018;20(6):507-516. https://doi.org/10.1615/intjmedmushrooms.2018026007
• 59. Kou RW, Han R, Gao YQ, Li D, Yin X, Gao JM. Anti-neuroinflammatory polyoxygenated lanostanoids from Chaga mushroom Inonotus obliquus. Phytochemistry, 2021;184:112647. https://doi.org/10.1016/j.phytochem.2020.112647
• 60. Wei J, Guo WH, Cao CY, Kou RW, Xu YZ, Górecki M, et al. Polyoxygenated cyathane diterpenoids from the mushroom Cyathus africanus, and their neurotrophic and anti-neuroinflammatory activities. Sci. Rep. 2018;8(1). https://doi.org/10.1038/s41598-018-20472-4
• 61. Han J, Chen Y, Bao L, Yang X, Liu D, Li S, et al. Anti-inflammatory and cytotoxic cyathane diterpenoids from the medicinal fungus Cyathus africanus. Fitoterapia. 2013; 84(1):22-31. https://doi.org/10.1016/j.fitote.2012.10.001
• 62. Xu Z, Yan S, Bi K, Han J, Chen Y, Wu Z, et al. Isolation and identification of a new anti-inflammatory cyathane diterpenoid from the medicinal fungus Cyathus hookeri Berk. Fitoterapia. 2013; 86(1):159-162. https://doi.org/10.1016/j.fitote.2013.03.002
• 63. Yin X, Qi J, Li Y, Bao Z, Du P, Kou R et al. Terpenoids with neurotrophic and anti-neuroinflammatory activities from the cultures of the fungus Cyathus stercoreus. Nat. Prod. Res. 2021;35(22):4524-4533. https://doi.org/10.1080/14786419.2020.1739043
• 64. Chong PS, Fung ML, Wong KH, Lim LW. Therapeutic potential of Hericium erinaceus for depressive disorder. Int. J. Mol. Sci. 2020;21(1):163. https://doi.org/10.3390/ijms21010163
• 65. Ma B-J, Shen J-W, Yu H-Y, Ruan Y, Wu T-T, Zhao X. Hericenones and erinacines: Stimulators of nerve growth factor (NGF) biosynthesis in Hericium erinaceus. Mycology. 2020;1(2):92-98. https://doi.org/10.1080/21501201003735556
• 66. Akihisa T, Nakamura Y, Tagata M, Tokuda H, Yasukawa K, Uchiyama E, et al. Anti-inflammatory and anti-tumor-promoting effects of triterpene acids and sterols from the fungus Ganoderma lucidum. Chem. Biodiversity. 2007;4:224-231. https://doi.org/10.1002/cbdv.200790027
• 67. Dudhgaonkar S, Thyagarajan A, Sliva D. Suppression of the inflammatory response by triterpenes isolated from the mushroom Ganoderma lucidum. Int. Immunopharmacol. 2009;9(11):1272-1280. https://doi.org/10.1016/j.intimp.2009.07.011
• 68. Sheng F, Zhang L, Wang S, Yang L, Li P. Deacetyl ganoderic acid F inhibits LPS-induced neural inflammation via NF-κB pathway both in vitro and in vivo. Nutrients. 2020;12(1). https://doi.org/10.3390/nu12010085
• 69. Li IC, Lee LY, Tzeng TT, Chen WP, Chen YP, Shiao YJ, et al. Neurohealth Properties of Hericium erinaceus Mycelia Enriched with Erinacines. Behav. Neurol. 2018;1:5802634. https://doi.org/10.1155/2018/5802634
• 70. Zhang XQ, Ip FCF, Zhang DM, Chen LX, Zhang W, Li YL, et al. Triterpenoids with neurotrophic activity from Ganoderma lucidum. Nat. Prod. Res. 2011;25(17):1607-1613. https://doi.org/10.1080/14786419.2010.496367
• 71. Lin CH, Hsiao LW, Kuo YH, Shih CC. Antidiabetic and antihyperlipidemic effects of sulphurenic acid, a triterpenoid compound from Antrodia camphorata, in streptozotocin-induced diabetic mice. Int. J. Mol. Sci. 2019;20(19). https://doi.org/10.3390/ijms20194897
• 72. Kuo YH, Lin CH, Shih CC. Dehydroeburicoic acid from Antrodia camphorata prevents the diabetic and dyslipidemic state via modulation of glucose transporter 4, peroxisome proliferator-activated receptor α expression and amp-activated protein kinase phosphorylation in high-fat-fed mice. Int. J. Mol. Sci. 2016;17(6):872. https://doi.org/10.3390/ijms17060872
• 73. Zhang B-B, Guan Y-Y, Hu P-F, Chen L, Xu G-R, Liu L, et al. Production of bioactive metabolites by submerged fermentation of the medicinal mushroom Antrodia cinnamomea: recent advances and future development. Crit. Rev. Biotechnol. 2019;39(4):541-554. https://doi.org/10.1080/07388551.2019.1577798
• 74. Fatmawati S, Kondo R, Shimizu K. Structure-activity relationships of lanostane-type triterpenoids from Ganoderma lingzhi as α-glucosidase inhibitors. Bioorg. Med. Chem. Lett. 2013;23(21):5900-5903. https://doi.org/10.1016/j.bmcl.2013.08.084
• 75. Zhao XR, Huo XK, Dong PP, Wang C, Huang SS, Zhang BJ, et al. Inhibitory effects of highly oxygenated lanostane derivatives from the fungus Ganoderma lucidum on p-glycoprotein and α-glucosidase. J. Nat. Prod. 2015;78(8):1868-1876. https://doi.org/10.1021/acs.jnatprod.5b00132
• 76. Fatmawati S, Shimizu K, Kondo R. Ganoderol B: A potent α-glucosidase inhibitor isolated from the fruiting body of Ganoderma lucidum. Phytomedicine. 2011;18(12): 1053-1055. https://doi.org/10.1016/j.phymed.2011.03.011
• 77. Kim D-H, Shim S-B, Kim N-J, Jang I-S. β-Glucuronidase-inhibitory activity and hepatoprotective effect of Ganoderma lucidum. Biol. Pharm. Bull. 1999;22(2):162-164. https://doi.org/10.1248/bpb.22.162
• 78. Chen XQ, Zhao J, Chen LX, Wang SF, Wang Y, Li SP. Lanostane triterpenes from the mushroom Ganoderma resinaceum and their inhibitory activities against α-glucosidase. Phytochemistry. 2018;149:103-115. https://doi.org/10.1016/j.phytochem.2018.01.007
• 79. Ying YM, Zhang LY, Zhang X, Bai HB, Liang DE, Ma LF, et al. Terpenoids with alpha-glucosidase inhibitory activity from the submerged culture of Inonotus obliquus. Phytochemistry. 2014;108:171-176. https://doi.org/10.1016/j.phytochem.2014.09.022
• 80. Sato M, Tai T, Nunoura Y, Yajima Y, Kawashima S, Tanaka K. Dehydrotrametenolic acid induces preadipocyte differentiation and sensitizes animal models of noninsulin-dependent diabetes mellitus to insulin. Biol. Pharm. Bull. 2022;25(1):81-86. https://doi.org/10.1248/bpb.25.81
• 81. Yeh CT, Rao YK, Yao CJ, Yeh CF, Li CH, Chuang SE, et al. Cytotoxic triterpenes from Antrodia camphorata and their mode of action in HT-29 human colon cancer cells. Cancer Lett. 2009;285(1):73-79. https://doi.org/10.1016/j.canlet.2009.05.002
• 82. Dasgupta A, Dey D, Ghosh D, Lai TK, Bhuvanesh N, Dolui S, et al. Astrakurkurone, a sesquiterpenoid from wild edible mushroom, targets liver cancer cells by modulating Bcl-2 family proteins. IUBMB Life. 2019;71(7):992-1002. https://doi.org/10.1002/iub.2047
• 83. Bhattarai G, Lee Y-H, Lee N-H, Lee I-K, Yun B-S, Hwang P-H, et al. Fomitoside-K from Fomitopsis nigra induces apoptosis of human oral squamous cell carcinomas (YD-10B) via mitochondrial Signaling Pathway. Biol. Pharm. Bull. 2012;35(10):1711-1719. https://doi.org/10.1248/bpb.b12-00297
• 84. Ma L, Chen H, Dong P, Lu X. Anti-inflammatory and anticancer activities of extracts and compounds from the mushroom Inonotus obliquus. Food Chem. 2013;139(1-4):503-508. https://doi.org/10.1016/j.foodchem.2013.01.030
• 85. Cheng S, Eliaz I, Lin J, Sliva D. Triterpenes from Poria cocos suppress growth and invasiveness of pancreatic cancer cells through the downregulation of MMP-7. Int. J. Oncol. 2013;42(6):1869-1874. https://doi.org/10.3892/ijo.2013.1902Hacettepe